纵横研报
Ticker Detail

603896.SHG

¥15.06+3.93% 寿仙谷 Biotechnology
00Reports China 医疗健康
Zhejiang Shouxiangu Pharm Co
医疗健康 · 生物科技

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China. It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products under the Shouxiangu brand. Zhejiang Shouxiangu Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Jinhua, China.

MARKET 市值 2.75B CNY 52W ¥12.62 – ¥23.04 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -8.5% ROE -0.5% 营业利润率 18.7% 净利润率 -1.8%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制